St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study

St. Paul, MN, March 9, 2004 -- St. Jude Medical, Inc. (NYSE: STJ) announced today that data from its RHYTHM (Resynchronization HemodYnamic Treatment for Heart Failure Management) ICD clinical trial showed a statistically significant improvement in peak VO2 and exercise duration for patients treated with cardiac resynchronization therapy (CRT). All prospectively defined primary safety and efficacy endpoints of the study were successfully met. The announcement was made today in conjunction with the American College of Cardiology's 2004 Scientific Session in New Orleans, Louisiana.

"The Epic HF ICD evaluated in this study effectively combines pacemaker therapy, defibrillation therapy and left-heart stimulation to treat the complexities of heart failure," said Kyong T. Turk, M.D., of the Nebraska Heart Institute, Lincoln, Nebraska, who enrolled the most patients in the RHYTHM clinical study. "These multiple sophisticated therapies in one compact, easy to implant device give me significant flexibility to optimize patient care."

The primary efficacy endpoint of the RHYTHM ICD study was improvement in cardiac function as measured by patient peak VO2 during cardiopulmonary exercise testing. The clinical trial was sized based on an expectation that the CRT arm of the study would show a 1.6 ml/kg/min improvement in peak VO2 compared with the control group, which did not have the CRT feature activated. The actual observed improvement level for CRT compared to control was 1.93 ml/kg/min, which was statistically significant (p=0.001). Secondary endpoints concerning NYHA class and Quality of Life were also statistically significantly improved with CRT (p=0.048 and p=0.009, respectively), with the six minute walk test demonstrating a strong trend toward significance (p=0.07). The study evaluated resynchronization effectiveness, defibrillation system efficacy, defibrillation system safety and left ventricle lead performance.

"This is a signif

Contact: mechal weiss
Edelman Public Relations

Page: 1 2 3

Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
5. New data on Orqis Medicals Cancion CRS to be reported at ACC
6. Medical technologies may hinder rather than help newborn survival
7. Medical meeting to feature research findings and disease prevention and health promotion sessions
8. LA BioMed Medical/Research briefs January 2005
9. Medical negligence system is secretive, unaccountable and unregulated
10. Dartmouth Medical School receives $1.6 million in AIDS funding
11. LA BioMed Medical/Research Briefs December 2004

Post Your Comments:

(Date:5/30/2020)... ... 29, 2020 , ... Segal Trials, a privately held network ... commemorated May, Mental Health Awareness Month, and May 20th, Clinical Trial Awareness Day, ... include their #StayConnected video series raising awareness of clinical trials and offering mental ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... is joining the clinically integrated network (CIN) and the group purchasing organization run ... Cardiovascular Institute to establish a heart failure program at Mon Health Medical Center. ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... is now manufacturing face shields to be used as personal protective equipment ... These face shields are single use, made to be worn by frontline healthcare ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... Pollack, University of Washington Professor of Bioengineering, Founder & Editor of scientific ... & Vapor ( https://www.amazon.com/Fourth-Phase-Water-Beyond-Liquid-ebook/dp/B00N2ASKF2 ) , https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water , * ...
(Date:5/26/2020)... ... May 26, 2020 , ... Today TRC Companies (“ TRC ”) announced ... that will help business owners and leaders assess whether their organizations are prepared to ... offering from TRC is intended to assist business leaders evaluate their readiness relative to ...
Breaking Medicine News(10 mins):
(Date:6/2/2020)... ... June 02, 2020 , ... ... announced today that in response to COVID-19 it is working with its corporate ... and on-site solutions, reimbursements, and a host of digital resources. Harmony’s leadership team ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... mobile and web based solution People1 Care to help organizations safely ... transition into the 'new normal’ through daily wellness screenings, social distancing support, and ...
(Date:5/30/2020)... ... 2020 , ... During a crisis, the platitude “stay strong” is well-intended, but ... developed and strengthened through hardship. Recent research conducted by PsychTests.com reveals that ... in order to stay strong in the face of adversity. It seems that resilience ...
Breaking Medicine Technology:
Cached News: